Newly approved PI provides treatment options
- PMID: 11364360
Newly approved PI provides treatment options
Abstract
AIDS: The Food and Drug Administration (FDA) recently approved nelfinavir (Viracept), the fourth protease inhibitor on the market. It is unclear where it fits in the treatment arsenal, although it appears to have fewer severe side effects than the other three protease inhibitors already being prescribed. One potential drawback to using the drug is that early data suggest that resistance to nelfinavir can cause cross-resistance to the other drugs.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous